Case Study: Sanofi’s acquisition of Ablynx for $4.8 bn
French drugmaker Sanofi has agreed to acquire Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion). This is second deal of... Read More
Lupin enters Indian OTC market
India’s second largest drug company Lupin Ltd has also entered the growing Over the Counter (OTC) market in the country. Indian OTC... Read More
Novatis’ LUTATHERA® Approval: First FDA Approval for a Peptide Receptor Radionuclide Therapy (PRRT)
Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that it has received US Food and... Read More
Pharma Case Study: Backward Integration: Ipca Laboratories acquisition of Pisgah Labs Inc.
What is backward integration? Backward integration strategy employed to expand profits and gain greater control over production of a product whereby a company... Read More
Licensing Case Study: Nuvo Ireland’s acquisition of US rights for Resultz from Piedmont Pharma
Posted on17 Jan 2018
Comments0
Nuvo Pharmaceuticals Inc. (Nuvo), a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, announced that its wholly... Read More
USFDA approval of Lynparza to Treat BRCA-mutated Metastatic Breast Cancer
The U.S. Food and Drug Administration (FDA) has approved Lynparza (olaparib) for a difficult-to-treat form of metastatic breast cancer. Patients with BRCA-mutated,... Read More